Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.

Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Fleshner NE, Finelli A, Kulkarni GS, Detsky AS, Satkunasivam R.

Can Urol Assoc J. 2018 Jun 19. doi: 10.5489/cuaj.5351. [Epub ahead of print]

PMID:
29940136
2.

Two Cases of Arterioureteral Fistula in the Setting of Previous Radiation Therapy and Indwelling Ureteral Stents: Results of Endovascular Management.

Chandrasekar T, Pugashetti N, Klaassen Z, Goldberg H, Dong P, Yap SA.

Clin Genitourin Cancer. 2018 Apr 28. pii: S1558-7673(18)30167-8. doi: 10.1016/j.clgc.2018.04.003. [Epub ahead of print] No abstract available.

PMID:
29776676
3.

Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 years of Age.

Goldberg H, Klaassen Z, Chandrasekar T, Wallis CJD, Toi A, Sayyid R, Bhindi B, Nesbitt M, Evans A, van der Kwast T, Sweet J, Perlis N, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta A, Fleshner N.

J Urol. 2018 May 11. pii: S0022-5347(18)43127-8. doi: 10.1016/j.juro.2018.05.017. [Epub ahead of print]

PMID:
29758220
4.

Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis.

Goldberg H, Klaassen Z, Chandrasekar T, Sayyid R, Kulkarni GS, Hamilton RJ, Fleshner NE.

Oncotarget. 2018 Apr 10;9(27):18797-18810. doi: 10.18632/oncotarget.24694. eCollection 2018 Apr 10.

5.

High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.

Chandrasekar T, Klaassen Z, Goldberg H, Sayyid RK, Kulkarni GS, Fleshner NE.

Oncotarget. 2018 Mar 30;9(24):16731-16743. doi: 10.18632/oncotarget.24675. eCollection 2018 Mar 30.

6.

Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.

Jazzar U, Yong S, Klaassen Z, Huo J, Hughes BD, Esparza E, Mehta HB, Kim SP, Tyler DS, Freedland SJ, Kamat AM, Wolf DV, Williams SB.

Cancer. 2018 Apr 16. doi: 10.1002/cncr.31404. [Epub ahead of print]

PMID:
29660813
7.

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Wallis CJD, Klaassen Z, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, Goldberg H, Boorjian SA, Leibovich B, Kulkarni GS, Shah PS, Bjarnason GA, Heng DYC, Satkunasivam R, Finelli A.

Eur Urol. 2018 Apr 13. pii: S0302-2838(18)30254-9. doi: 10.1016/j.eururo.2018.03.036. [Epub ahead of print] Review.

PMID:
29656851
8.

RE: Rydzewska et al. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. Eur J Cancer. 2017 Oct; 84:88-101.

Wallis CJD, Klaassen Z.

Eur J Cancer. 2018 May;94:216-217. doi: 10.1016/j.ejca.2018.01.115. Epub 2018 Mar 21. No abstract available.

PMID:
29573942
9.

Editorial Comment.

Klaassen Z.

Urology. 2018 Apr;114:112. doi: 10.1016/j.urology.2017.11.061. Epub 2018 Mar 14. No abstract available.

PMID:
29550220
10.

Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.

Lokeshwar SD, Talukder A, Yates TJ, Hennig MJP, Garcia-Roig M, Lahorewala SS, Mullani NN, Klaassen Z, Kava BR, Manoharan M, Soloway MS, Lokeshwar VB.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):464-472. doi: 10.1158/1055-9965.EPI-17-0700. Epub 2018 Feb 12.

PMID:
29440068
11.

Case - Foamy, high-grade prostatic intraepithelial neoplasia: A false positive for prostate cancer on multiparametric magnetic resonance imaging?

Chandrasekar T, Goldberg H, Klaassen Z, Perlis N, Finelli A, Evans A, Ghai S.

Can Urol Assoc J. 2018 May;12(5):E256-E259. doi: 10.5489/cuaj.4860. Epub 2018 Feb 6. No abstract available.

12.

Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives.

Sayyid RK, Sayyid AK, Klaassen Z, Hersey K, Goldberg H, Perlis N, Ahmad A, Leao R, Chandrasekar T, Fadaak K, Madi R, Terris MK, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Fleshner NE.

Can Urol Assoc J. 2018 May;12(5):E210-E218. doi: 10.5489/cuaj.4922. Epub 2018 Feb 6.

13.

Changing Trends for Suicidal Death in Patients With Bladder Cancer: A 40+ Year Population-level Analysis.

Klaassen Z, Goldberg H, Chandrasekar T, Arora K, Sayyid RK, Hamilton RJ, Fleshner NE, Williams SB, Wallis CJD, Kulkarni GS.

Clin Genitourin Cancer. 2018 Jun;16(3):206-212.e1. doi: 10.1016/j.clgc.2017.12.016. Epub 2018 Jan 5.

PMID:
29395948
15.

Analysis of Suicide Risk in Patients with Penile Cancer and Review of the Literature.

Simpson WG, Klaassen Z, Jen RP, Hughes WM 5th, Neal DE Jr, Terris MK.

Clin Genitourin Cancer. 2018 Apr;16(2):e257-e261. doi: 10.1016/j.clgc.2017.09.011. Epub 2017 Oct 3. Review.

PMID:
29126815
16.

Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines.

Klaassen Z, Arora K, Goldberg H, Chandrasekar T, Wallis CJD, Sayyid RK, Fleshner NE, Finelli A, Kutikov A, Violette PD, Kulkarni GS.

J Urol. 2018 Apr;199(4):906-914. doi: 10.1016/j.juro.2017.08.130. Epub 2017 Nov 4. Review.

PMID:
29113840
17.

Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis.

Wallis CJD, Klaassen Z, Bhindi B, Goldberg H, Chandrasekar T, Farrell AM, Boorjian SA, Kulkarni GS, Karnes RJ, Satkunasivam R.

Eur Urol. 2018 Jun;73(6):834-844. doi: 10.1016/j.eururo.2017.10.002. Epub 2017 Oct 14. Review.

PMID:
29037513
18.

Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer.

Goldberg H, Klaassen Z, Chandrasekar T, Fleshner N.

Curr Opin Urol. 2018 Jan;28(1):46-54. doi: 10.1097/MOU.0000000000000455.

PMID:
29028765
19.

STAMPEDE-ing towards androgen biosynthesis inhibition for treatment of high-risk hormone-naïve prostate cancer: changing the LATITUDE.

Klaassen Z, Murphy DG.

BJU Int. 2018 Jan;121(1):9-11. doi: 10.1111/bju.14050. Epub 2017 Oct 24. Review. No abstract available.

PMID:
28990349
20.

Identifying Psychosocial Distress and Stressors Using Distress-screening Instruments in Patients With Localized and Advanced Penile Cancer.

Leem S, Klaassen Z.

Clin Genitourin Cancer. 2017 Sep 8. pii: S1558-7673(17)30278-1. doi: 10.1016/j.clgc.2017.09.003. [Epub ahead of print] No abstract available.

PMID:
28967506
21.

Decreasing suicide risk among patients with prostate cancer: Implications for depression, erectile dysfunction, and suicidal ideation screening.

Klaassen Z, Arora K, Wilson SN, King SA, Madi R, Neal DE Jr, Kurdyak P, Kulkarni GS, Lewis RW, Terris MK.

Urol Oncol. 2018 Feb;36(2):60-66. doi: 10.1016/j.urolonc.2017.09.007. Epub 2017 Sep 28. Review.

PMID:
28964659
22.

Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes.

Chandrasekar T, Goldberg H, Klaassen Z, Sayyid RK, Hamilton RJ, Fleshner NE, Kulkarni GS.

Urol Oncol. 2018 Jan;36(1):13.e11-13.e18. doi: 10.1016/j.urolonc.2017.08.023. Epub 2017 Sep 14.

PMID:
28919181
23.

Retzius-Sparing Robotic-Assisted Laparoscopic Radical Prostatectomy: A Safe Surgical Technique with Superior Continence Outcomes.

Sayyid RK, Simpson WG, Lu C, Terris MK, Klaassen Z, Madi R.

J Endourol. 2017 Dec;31(12):1244-1250. doi: 10.1089/end.2017.0490.

PMID:
28859492
24.

Testosterone Responders to Continuous Androgen Deprivation Therapy Show Considerable Variations in Testosterone Levels on Followup: Implications for Clinical Practice.

Sayyid RK, Sayyid AK, Klaassen Z, Fadaak K, Goldberg H, Chandrasekar T, Ahmad A, Leao R, Perlis N, Chadwick K, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta AR, Fleshner NE.

J Urol. 2018 Jan;199(1):251-256. doi: 10.1016/j.juro.2017.07.078. Epub 2017 Jul 25.

PMID:
28751266
25.

Metastatic renal cell carcinoma: Patterns and predictors of metastases-A contemporary population-based series.

Chandrasekar T, Klaassen Z, Goldberg H, Kulkarni GS, Hamilton RJ, Fleshner NE.

Urol Oncol. 2017 Nov;35(11):661.e7-661.e14. doi: 10.1016/j.urolonc.2017.06.060. Epub 2017 Jul 17.

PMID:
28728748
26.

Contemporary cost-consequence analysis of blue light cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer.

Klaassen Z, Li K, Kassouf W, Black PC, Dragomir A, Kulkarni GS.

Can Urol Assoc J. 2017 Jun;11(6):173-181. doi: 10.5489/cuaj.4568.

27.

Pursuing fellowship training: There are no traffic jams along the extra mile.

Klaassen Z.

Can Urol Assoc J. 2017 Jun;11(6):161-162. doi: 10.5489/cuaj.4651. No abstract available.

28.

Editorial Comment.

Klaassen Z.

Urology. 2017 Aug;106:131. doi: 10.1016/j.urology.2017.03.050. Epub 2017 Jun 1. No abstract available.

PMID:
28579212
29.

Thoracic Trauma in the Oldest of the Old: An Analysis of the Nationwide Inpatient Sample.

Mentzer CJ, Walsh NJ, Talukder A, Klaassen Z, Leibrandt R, Ferdinand CH, O'Malley KF.

Am Surg. 2017 May 1;83(5):491-494.

PMID:
28541860
30.

Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?

Kulkarni GS, Klaassen Z.

Eur Urol. 2017 Oct;72(4):488-489. doi: 10.1016/j.eururo.2017.04.028. Epub 2017 May 6. No abstract available.

PMID:
28483329
31.

Comorbidity Is a Competing Factor for Disease Recurrence Postnephrectomy.

Reinstatler L, Klaassen Z, Madi R, Terris MK, Moses KA.

South Med J. 2017 May;110(5):369-374. doi: 10.14423/SMJ.0000000000000651.

PMID:
28464180
32.
33.

Zero-fragment Nephrolithotomy: A Multi-center Evaluation of Robotic Pyelolithotomy and Nephrolithotomy for Treating Renal Stones.

Swearingen R, Sood A, Madi R, Klaassen Z, Badani K, Elder JS, Wood K, Hemal A, Ghani KR.

Eur Urol. 2017 Dec;72(6):1014-1021. doi: 10.1016/j.eururo.2016.10.021. Epub 2016 Oct 27.

PMID:
28085668
34.

Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.

Klaassen Z, Howard LE, de Hoedt A, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Freedland SJ.

Cancer. 2017 May 1;123(9):1528-1535. doi: 10.1002/cncr.30505. Epub 2016 Dec 27.

35.

Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.

Klaassen Z, Howard LE, Moreira DM, Andriole GL Jr, Terris MK, Freedland SJ.

Prostate. 2017 Apr;77(5):466-470. doi: 10.1002/pros.23285. Epub 2016 Dec 19.

PMID:
27990661
36.

The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy.

Zhao Z, Reinstatler L, Klaassen Z, Xu Y, Yang X, Madi R, Terris MK, Qian SY, Kelavkar U, Moses KA.

PLoS One. 2016 Nov 23;11(11):e0166594. doi: 10.1371/journal.pone.0166594. eCollection 2016.

37.

Dr. Hugh Hampton Young's Impact on Venereal Disease During World War I: The Chaste of American Soldiers.

Dmytruk K, Klaassen Z, Wilson SN, Kabaria R, Kemper MW, Terris MK, Lewis RW, Neal DE Jr, Smith AM.

Urology. 2017 Jan;99:10-13. doi: 10.1016/j.urology.2016.08.043. Epub 2016 Sep 21. No abstract available.

PMID:
27664906
38.

Re: Mental Health Outcomes in Elderly Men with Prostate Cancer.

Peard L, Falkenstrom A, Klaassen Z, Terris MK.

Eur Urol. 2016 Jul;70(1):206-7. doi: 10.1016/j.eururo.2016.03.061. Epub 2016 Apr 18. No abstract available.

PMID:
27302293
39.

Female, Black, and Unmarried Patients Are More Likely to Present With Metastatic Bladder Urothelial Carcinoma.

Klaassen Z, DiBianco JM, Jen RP, Evans AJ, Reinstatler L, Terris MK, Madi R.

Clin Genitourin Cancer. 2016 Oct;14(5):e489-e492. doi: 10.1016/j.clgc.2016.04.006. Epub 2016 Apr 29.

PMID:
27212042
40.

Renal cell carcinoma: links and risks.

Kabaria R, Klaassen Z, Terris MK.

Int J Nephrol Renovasc Dis. 2016 Mar 7;9:45-52. doi: 10.2147/IJNRD.S75916. eCollection 2016. Review.

41.

Continent Catheterizable Vesicostomy: An Alternative Surgical Modality for Pediatric Patients With Large Bladder Capacity.

Peard L, Fox PJ, Andrews WM, Chen R, McCraw CO, Klaassen Z, Neal DE Jr.

Urology. 2016 Jul;93:217-22. doi: 10.1016/j.urology.2016.03.018. Epub 2016 Mar 15.

PMID:
26993353
42.

Suicide Risk in Patients With Bladder Cancer: A Call to Action.

Harper BT, Klaassen Z, DiBianco JM, Yaguchi G, Jen RP, Terris MK.

J Wound Ostomy Continence Nurs. 2016 Mar-Apr;43(2):170-1. doi: 10.1097/WON.0000000000000187. No abstract available.

PMID:
26938166
43.

Beyond biology: the impact of marital status on survival of patients with adrenocortical carcinoma.

Klaassen Z, Reinstatler L, Terris MK, Underwood W 3rd, Moses KA.

Int Braz J Urol. 2015 Nov-Dec;41(6):1108-15. doi: 10.1590/S1677-5538.IBJU.2014.0348.

44.

The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer.

Klaassen Z, DiBianco JM, Jen RP, Harper B, Yaguchi G, Reinstatler L, Woodard C, Moses KA, Terris MK, Madi R.

J Wound Ostomy Continence Nurs. 2016 Mar-Apr;43(2):152-7. doi: 10.1097/WON.0000000000000188.

PMID:
26680629
45.

Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.

Harlow BL, Klaassen Z, Holzman S, Reinstatler L, Franken AA, Kavuri SK, Terris MK, Master VA, Moses KA.

Clin Genitourin Cancer. 2016 Apr;14(2):e171-5. doi: 10.1016/j.clgc.2015.10.013. Epub 2015 Nov 2.

PMID:
26613833
46.

Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.

Klaassen Z, Howard L, Terris MK, Aronson WJ, Cooperberg MR, Amling CL, Kane CJ, Freedland SJ.

Cancer Epidemiol. 2015 Dec;39(6):1066-70. doi: 10.1016/j.canep.2015.09.007. Epub 2015 Oct 6.

47.

Clinical Disparities for Minorities and Foreign-Born Men With Undescended Versus Descended Testicular Germ Cell Tumors.

Klaassen Z, Reinstatler L, Wilson SN, Ellington C, Li Q, Terris MK, Moses KA.

Clin Genitourin Cancer. 2016 Jun;14(3):e251-5. doi: 10.1016/j.clgc.2015.08.004. Epub 2015 Sep 2.

PMID:
26428610
48.

Body mass index and comorbidity are associated with postoperative renal function after nephrectomy.

Reinstatler L, Klaassen Z, Barrett B, Terris MK, Moses KA.

Int Braz J Urol. 2015 Jul-Aug;41(4):697-704. doi: 10.1590/S1677-5538.IBJU.2014.0383.

49.

A Paratesticular Serous Borderline Tumor in a Pediatric Patient With Proteus Syndrome.

Klaassen Z, Fox PJ, McLees L, Zheng M, Sharma S, Donohoe JM, Neal DE Jr.

Urology. 2015 Dec;86(6):1218-21. doi: 10.1016/j.urology.2015.07.023. Epub 2015 Sep 11.

PMID:
26368507
50.

How can we decrease suicide risk in cases of genitourinary cancer?

Klaassen Z, Yaguchi G, Terris MK.

Future Oncol. 2015;11(15):2113-5. doi: 10.2217/fon.15.131. No abstract available.

PMID:
26235177

Supplemental Content

Loading ...
Support Center